Evaluation of OPC-17116 against important pathogens that cause respiratory tract infections.
The antibacterial activity of OPC-17116, a new fluoroquinolone antibacterial agent, against important pathogens that cause respiratory tract infections was evaluated in vitro and in vivo and compared with those of ciprofloxacin, ofloxacin, and norfloxacin. The pharmacokinetic profiles of OPC-17116 w...
Kaydedildi:
| Yayımlandı: | Antimicrob Agents Chemother |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1994
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284741/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7840567/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.10.2340 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|